We would love to hear your thoughts about our site and services, please take our survey here.
Bear in mind we are now sitting around our all time high, pre dilution. For a quiet period with no news, this is impressive. A £2.50 prediction with positive P3 results or EUA is ludicrous. The potential here is staggering - into the multi billion pound valuation bracket just for government stockpiling alone!
Forgive me if im totally wrong here but there was very little mentioned about the R number and also different mutations of the virus - the two most important factors to date!
Instead, we have irreversible ‘roadmap’ with focus being on vaccines which have almost unknown future effects. Nothing has changed with COVID and new strains will almost certainly affect this roadmap.
$1 - $1.5 billion? Surely that would be giving it away. The potential for this is massive and for 15 plus years of work and research i dont think they would entertain an offer of $1.5 billion for takeover. If P3 results are positive or Activ2 results deem sufficient enough for EUA then this has the potential for a tens of billions offer on the forecast of doses per month alone, never mind government stockpiling!